Jaguar Animal Health (NASDAQ:JAGX) Shares Pass Below 50 Day Moving Average – Time to Sell?

Jaguar Animal Health, Inc. (NASDAQ:JAGX)’s stock price crossed below its 50 day moving average during trading on Monday . The stock has a 50 day moving average of $0.93 and traded as low as $0.59. Jaguar Animal Health shares last traded at $0.6320, with a volume of 215,884 shares changing hands.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on JAGX. Wall Street Zen downgraded Jaguar Animal Health to a “strong sell” rating in a research report on Friday, January 23rd. Weiss Ratings reissued a “sell (e+)” rating on shares of Jaguar Animal Health in a report on Thursday, January 22nd. One analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, Jaguar Animal Health has an average rating of “Hold” and a consensus target price of $60.00.

Jaguar Animal Health Stock Down 2.4%

The company has a market cap of $2.30 million, a P/E ratio of -0.02 and a beta of 0.09. The stock has a 50-day moving average of $0.92 and a two-hundred day moving average of $1.52. The company has a debt-to-equity ratio of 4.08, a quick ratio of 0.52 and a current ratio of 0.81.

About Jaguar Animal Health

Jaguar Animal Health, Inc is a biopharmaceutical company focused on the development and commercialization of novel therapeutics for the gastrointestinal health of food-producing animals, with an emphasis on swine and poultry. The company’s research and development efforts target common enteric disorders such as post-weaning diarrhea in pigs and clostridial overgrowth in broiler chickens, aiming to provide effective alternatives to traditional antibiotic treatments.

Jaguar Animal Health was formed in early 2019 through the acquisition of the animal health business of Aratana Therapeutics by Actinium Animal Health, followed by a corporate rebranding.